The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Conflicting data aside, contraception experts agree that ulipristal acetate, or ella, is a more effective option for people ...

Patients who took a single high dose of GUBamy lost 3% of their body weight during the 6-week trial, while those on a placebo ...

Presented New CRB-913 Pre-Clinical Data at Obesity Week 2024 - Phase 1 Trial Expected to Commence in Q1 2025 ...

Novo Nordisk (NVO) announced Friday a pivotal Phase 3 trial designed to test its weight loss therapy semaglutide on patients with a liver disease called metabolic dysfunction-associated ...

A hospital worker hid his "sinister and predatory" side under the veneer of a "hardworking and dedicated professional", a trial has heard ... He will do anything to gain access, under a medical ...